HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Use of miocamycin in the acute exacerbation of chronic obstructive bronchopneumopathy. Case material contribution].

Abstract
18 patients with chronic obstructive bronchitis were treated with 900 mg myomycin a day. The clinical parameters examined were the quantity and organoleptic characteristics of the expectoration, coughing, and body temperature. These parameters were studied immediately before and 7.14 and 21 days after the start of treatment. Myomycin was found to be satisfactorily effective with minimal toxicity and well tolerated.
AuthorsC Miravalle, A Ardizzi, S Barberis, F Galietti, G E Giorgis, A Oliaro
JournalMinerva medica (Minerva Med) Vol. 78 Issue 9 Pg. 623-6 (May 15 1987) ISSN: 0026-4806 [Print] Italy
Vernacular TitleL'impiego della miocamicina nelle riacutizzazioni della broncopneumopatia cronica ostruttiva. Contributo casistico.
PMID3495753 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Leucomycins
  • Miocamycin
Topics
  • Aged
  • Cough (drug therapy)
  • Female
  • Fever (drug therapy)
  • Humans
  • Leucomycins (therapeutic use)
  • Lung Diseases, Obstructive (complications, drug therapy)
  • Male
  • Middle Aged
  • Miocamycin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: